Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow
Publication year
2021Source
Clinical Chemistry, 67, 12, (2021), pp. 1689-1998ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Laboratory Medicine
Analytical Chemistry
Journal title
Clinical Chemistry
Volume
vol. 67
Issue
iss. 12
Page start
p. 1689
Page end
p. 1998
Subject
Analytical Chemistry; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 6: Metabolic Disorders RIMLS: Radboud Institute for Molecular Life Sciences; Laboratory Medicine - Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [246515]
- Electronic publications [134102]
- Faculty of Medical Sciences [93308]
- Faculty of Science [38028]
- Open Access publications [107634]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.